|
MMD expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.028400E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.266600E-01 |
| Normal-vs-Stage2 |
1.038640E-01 |
| Normal-vs-Stage3 |
3.602600E-01 |
| Normal-vs-Stage4 |
9.193600E-01 |
| Stage1-vs-Stage2 |
3.677000E-01 |
| Stage1-vs-Stage3 |
9.640200E-01 |
| Stage1-vs-Stage4 |
2.176400E-01 |
| Stage2-vs-Stage3 |
4.786400E-01 |
| Stage2-vs-Stage4 |
9.712300E-02 |
| Stage3-vs-Stage4 |
3.769800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.326200E-01 |
| Normal-vs-AfricanAmerican |
3.401900E-03 |
| Normal-vs-Asian |
5.201400E-01 |
| Caucasian-vs-AfricanAmerican |
9.006500E-04 |
| Caucasian-vs-Asian |
2.668000E-01 |
| AfricanAmerican-vs-Asian |
9.798900E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.617600E-01 |
| Normal-vs-Female |
7.173700E-02 |
| Male-vs-Female |
4.363500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.354400E-01 |
| Normal-vs-Age(41-60Yrs) |
2.146800E-01 |
| Normal-vs-Age(61-80Yrs) |
4.872200E-01 |
| Normal-vs-Age(81-100Yrs) |
2.334300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.227400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.294000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.468600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.203000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.576620E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.450300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.102400E-03 |
| Normal-vs-Grade 2 |
4.009400E-01 |
| Normal-vs-Grade 3 |
1.574800E-01 |
| Normal-vs-Grade 4 |
8.973600E-01 |
| Grade 1-vs-Grade 2 |
1.404270E-03 |
| Grade 1-vs-Grade 3 |
3.624700E-03 |
| Grade 1-vs-Grade 4 |
9.043100E-04 |
| Grade 2-vs-Grade 3 |
4.303400E-01 |
| Grade 2-vs-Grade 4 |
4.706000E-01 |
| Grade 3-vs-Grade 4 |
1.696990E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.388300E-02 |
| Normal-vs-ccB subtype |
7.358400E-01 |
| ccA subtype-vs-ccB subtype |
9.351300E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.927600E-01 |
| Normal-vs-N1 |
9.636200E-01 |
| N0-vs-N1 |
6.174400E-01 |
|
|
